Cent Eur J Public Health 2008, 16(Supplement):S21-S24

Cervical Screening in England: Liquid-Based Cytology in the Context of Modernization of the NHS Cervical Screening Programme

Amanda Herbert
Guy's and St Thomas' NHS Foundation Trust, London, UK

The article will briefly explain the processes of organized screening in the NHS Cervical Screening Programme (NHSCP). Quality control is well established and monitored by regional quality assurance reference centres. The final outcome of screening is also monitored by national cervical cancer mortality and incidence rates: data will be presented for rates of in situ and invasive cervical carcinoma before and after the introduction of organized screening. The NHSCSP is using the introduction of liquid-based cytology as a platform for modernization, which is planned to include high-risk human papillomavirus (HR HPV) testing for low-grade cytology triage as well as a test of cure after treatment. Trials of computer-assisted screening are also in progress. High standards of quality control will be needed in the era of vaccination, when prevalence of preinvasive and invasive cervical cancer will decline. The NHSCSP is well placed to take on these challenges, if necessary by introducing primary HR HPV testing so that cytology screening can be concentrated on women who are genuinely at risk.

Klíčová slova: screening, cervical cancer, liquid-based cytology, England

Zveřejněno: 1. duben 2008  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Herbert A. Cervical Screening in England: Liquid-Based Cytology in the Context of Modernization of the NHS Cervical Screening Programme. Cent Eur J Public Health. 2008;16(Supplement):S21-24.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Moller H, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and effects of screening. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):677-86. Přejít k původnímu zdroji... Přejít na PubMed...
    2. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004 Jul 17-23;364 (9430):249-56. Přejít k původnímu zdroji... Přejít na PubMed...
    3. National Institute for Clinical Excellence (NICE). Guidance on the use of liquid-based cytology for cervical screening. Technology appraisal no. 69. London: National Institute for Clinical Excellence; 2003.
    4. NHS Cancer Screening Programmes. Audit of invasive cervical cancers [monograph on the Internet]. NHSCSP Publication No. 28. Sheffield: NHS Cancer Screening Programmes; 2006 [cited 2008 Mar 17].Available from: http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp28.html.
    5. NHS Cancer Screening Programmes. Disclosure of Audit Results in Cancer Screening.Advice on Best Practice [monograph on the Internet]. Patnick J, editor. Cancer Screening Series No 3. Sheffield: NHS Cancer Screening Programmes; 2006 Apr [cited 2008 Mar 17]. Available from: http://www.cancerscreening.nhs.uk/publications/cs3.html.
    6. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet. 2003 Dec 6;362(9399):1871 Přejít k původnímu zdroji... Přejít na PubMed...
    7. Kitchener HK, Almonte M, Wheeler P, Desai M, Gilham C, Bailey A, et al. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer. 2006 Jul 3;95(1):56-61. Přejít k původnímu zdroji... Přejít na PubMed...
    8. NationalStatistics [homepage on the Internet]. Cancer Statistics: Registrations Series MB1. Newport: Office for National Statistics [cited 2008 Mar 17]. Available from: http://www.statistics.gov.uk/statbase/product.asp?vlnk=8843.
    9. Kyrgiou M, Koliopoulos G, Martin-Hirch P, Arbyn M, Prendiville W, Paraskevaidis W. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006 Feb 11; 367(9509):489-98. Přejít k původnímu zdroji... Přejít na PubMed...
    10. Rieck GC, TristramA, HaukeA, Fielder H, FianderAN. Cervical screening in 20-24-year olds. J Med Screen. 2006;13(2):64-71; discussion 62-3. Přejít k původnímu zdroji... Přejít na PubMed...
    11. Herbert A, Holdsworth G, Kubba AA. Cervical screening: why young women should be encouraged to be screened. J Fam Plann Reprod Health Care. 2008 Jan;34(1):21-5. Přejít k původnímu zdroji... Přejít na PubMed...
    12. Cervical ScreeningWales. Liquid Based Cytology Project. Project Report. 2003 Nov.
    13. Scottish Cervical Screening Programme. Feasibility of Introducing Liquid Based Cytology. Edinburgh: Scottish Cervical Screening Programme; 2002.
    14. Moss SM, GrayA, Legood R, Henstock E. Evaluation of HPV/LBC: Cervical Screening Pilot Studies. First report of the Department of Health on evaluation of LBC. 2003 Jan rev. [monograph on the Internet]. Sheffield: NHS Cancer Screening Programmes; 2002 c [cited Mar 17]. Available from: http://www.cancerscreening.nhs.uk/cervical/lbc-imp.html.
    15. Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N. Liquidbased cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess. 2004 May;8(20): iii, 1-78. Přejít k původnímu zdroji...
    16. Davey E, BarrattA, Irwig L, Chan SF, Macaskill P, Mannes P, et al. Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet. 2006 Jan 14;367(9505):122-32. Přejít k původnímu zdroji... Přejít na PubMed...
    17. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, SiebersAG, Bulten J. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol. 2008 Jan;111(1):167-77. Přejít k původnímu zdroji... Přejít na PubMed...
    18. DeMay R M. Cytopathology of false negatives preceding cervical carcinoma. Am J Obstet Gynecol. 1996 Oct;175(4 Pt 2):1110-3. Přejít k původnímu zdroji...
    19. Herbert A, Cully N, Culora G, Middleton M. Inadequate and abnormal cytology rates after the introduction of liquid-based cytology: a local method of assessing ThinPrep adequacy. Cytopathology. 2007 Sep;18 Suppl 1:21-2.
    20. Umana A, Kubba AA, Dunsmore H, Jokhan AR, Herbert A. A study to determine whether there is significant cell loss on the discarded ThinPrep broom when used for cervical cytology. Cytopathology. 2006 Sep;17 Suppl 1:15-6. Přejít k původnímu zdroji...
    21. Bolick DR, Kerr J, Staley BE, Ke Lin K. Effect of cellularity in the detection rates of high grade and low grade squamous intraepithelial lesions. Acta Cytol. 2002;46:922-3.
    22. Solomon D, Nayar R. The Bethesda system for reporting cervical cytology. Definitions, criteria and explanatory notes. 2nd ed. New York: Springer-Verlag; 2004. Přejít k původnímu zdroji...
    23. NHS Cervical Screening Programmes.Taking samples for cervical screening: a resource pack for screeners [monograph on the Internet]. NHSCSP Publication No. 23. Sheffield: NHS Cancer Screening Programmes; 2006 [cited Mar 17]. Available from: http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp23.html.
    24. European Commission. EU guidelines for QualityAssurance in Cervical Cancer Screening. 2nd ed. Luxembourg: Office for Official Publications of the European Communities, 2008.
    25. M.Arbyn,A. Herbert, U. Schenck, P. Nieminen, J. Jordan, E. Mcgoogan, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquidbased cytology. Cytopathology. 2007 Jun;18(3):133-9. Přejít k původnímu zdroji... Přejít na PubMed...
    26. NHS Cancer Screening Programmes. Colposcopy and Programme Management : Guidelines for the NHS Cervical Screening Programme. NHSCSP Publication No 20. Sheffield: NHS Cancer Screening Programmes; 2004.
    27. Department of Health [homepage on the Internet]. Patnick J. HPV vaccination: likely impact on NHS cervical screening programme [cited Mar 17]. Available from: http://www.advisorybodies.doh.gov.uk/JCVI/foiHPVsubgrouppapers0707-cervicalscreen.pdf.
    28. NHS Cervical Screening Programme [monograph on the Internet]. Patnick, J, editor. Annual Review 2007. Sheffield: NHS Cervical Screening Programme; 2008 [cited Mar 17].Available from: http://cancerscreening.org.uk/cervical/publications/2007review.html.
    29. Confortini M, Bonardi L, Bulgaresi P, Cariaggi MP, Cecchini S, Ciatto S, et al. A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device. Cancer. 2003 Jun 25;99(3):129-34. Přejít k původnímu zdroji... Přejít na PubMed...
    30. Davey E, d'Assuncao J, Irwig L, Macaskill P, Chan SF, Richards A, Farnsworth A. Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study. BMJ. 2007 Jul 7;335(7609):31. Přejít k původnímu zdroji... Přejít na PubMed...

    Zpět na obsah